# VINCERE BIOSCIENCES, INC.: IND-enabling studies of a USP30 inhibitor for acute kidney injury

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | VINCERE BIOSCIENCES, INC. |
| Location | Cambridge, MA |
| Project | IND-enabling studies of a USP30 inhibitor for acute kidney injury |
| Project number | 1R44DK143820-01A1 |
| Mechanism | R44 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $1,297,479 |
| Awarded | 2026-08-28 |
| Project period | 2026-08-28 to 2028-05-31 |
| UEI | UFN3TELC89N7 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11256218). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.